Form 4: Colgate-Palmolive CLO Receives Equity Awards

Colgate-Palmolive's Chief Legal Officer and Secretary, Jennifer Daniels, was granted restricted stock units and stock options as part of the company's incentive compensation plan.

Summary

• Jennifer Daniels, the Chief Legal Officer and Secretary of Colgate-Palmolive Co. (CL), was granted equity awards on September 11, 2025.
• The awards include 4,592 restricted stock units (RSUs) and options to purchase 31,796 shares of common stock.
• The restricted stock units vest in equal one-third installments on the first, second, and third anniversaries of the grant date.
• The stock options have an exercise price of $84.06 and become exercisable in equal annual installments over three years, beginning on the first anniversary of the grant date.
• The stock options are set to expire on September 11, 2033.
• Following these transactions, Ms. Daniels directly holds 77,980 shares of common stock and 31,796 stock options, and indirectly holds 1,813 shares through the company's 401(k) plan.

Sentiment

Score: 7

Explanation: The filing indicates routine executive compensation, which is generally positive for aligning management incentives with shareholder interests, but does not contain new strategic or financial performance information.

Positives

• The equity grants align management incentives with shareholder interests through long-term performance-based awards.
• The awards are part of a standard incentive compensation plan, indicating ongoing strategies for executive retention and motivation.

Future Outlook

The equity grants are designed to incentivize long-term performance and align executive interests with shareholder value creation over the coming years, with vesting and exercisability extending through 2028 for RSUs and 2033 for options.

Industry Context

Equity grants are a common practice across industries, particularly in consumer staples, to retain key executives and motivate them to achieve long-term strategic objectives. These grants are consistent with typical executive compensation structures in large, established companies like Colgate-Palmolive.

Comparison to Industry Standards

• The structure of these equity awards, including multi-year vesting for RSUs and options with an eight-year term, is standard for executive compensation packages in the consumer staples sector.
• Companies like Procter & Gamble (PG) and Unilever (UL) frequently utilize similar long-term incentive plans to align executive performance with shareholder returns.
• The exercise price of $84.06 for the options reflects the market price at the time of grant, a common practice to ensure options are 'at-the-money' upon issuance.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential for increased long-term value creation due to aligned executive incentives.
• Employees: Reflects standard executive compensation practices within the company.

Next Steps

• Jennifer Daniels will continue to hold and vest her restricted stock units over the next three years.
• Jennifer Daniels will be able to exercise her stock options in annual installments over the next three years, starting September 11, 2026.

Key Dates

Recommendation

This Form 4 filing details routine equity grants to an executive officer as part of an existing incentive compensation plan. While these grants align management interests with long-term shareholder value, they do not provide new material information regarding the company's operational performance, strategic direction, or financial health that would warrant a change in investment recommendation. The filing confirms standard corporate governance practices for executive compensation.

Keywords

Colgate-Palmolive, CL, Jennifer Daniels, Chief Legal Officer, Secretary, Restricted Stock Units, Stock Options, Equity Grant, Incentive Compensation, Insider Transaction, Form 4